This is a Louisiana news story, published by Condé Nast, that relates primarily to Thomas Pressly news.
For more Louisiana news, you can click here:
more Louisiana newsFor more Thomas Pressly news, you can click here:
more Thomas Pressly newsFor more women's health news, you can click here:
more women's health newsFor more news from Condé Nast, you can click here:
more news from Condé NastOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like women's health news, you might also like this article about
abortion bans. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest abortion drug news, total abortion bans news, women's health news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
extreme abortion bansCondé Nast
•55% Informative
Lawmakers in Louisiana are proposing legislation that would classify mifepristone and misoprostol as controlled dangerous substances on par with opioids and other highly addictive prescription drugs.
The legislation was sponsored by Republican state senator Thomas Pressly , whose sister testified that her then husband spiked her drink with an abortion drug, which caused her to have “intense cramping”.
VR Score
39
Informative language
28
Neutral language
32
Article tone
semi-formal
Language
English
Language complexity
62
Offensive language
likely offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
detected
Time-value
short-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links